ObaClin ApS: Financial statements 2023
CVR: 43789244
Source: annual report 2023, Danish Business Authority
19/01/2023 – 31/12/2023
ObaClin ApS (CVR 43789244) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,988 and a net result of DKK -12,988. Equity in the 2023 report amounted to DKK 27,012. The solvency ratio was 16.2%.
- Gross Profit
- DKK -2,988
- Profit/Loss
- DKK -12,988
- Equity
- DKK 27,012
- Total Assets
- DKK 166,416
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of January 19, 2023, Rikke Hagmann Schmidt is registered as director of ObaClin ApS.
As of January 19, 2023, Rikke Hagmann Schmidt is registered as an owner of ObaClin ApS with an ownership share of 100%.
ObaClin ApS was founded on January 19, 2023.
About ObaClin ApS
ObaClin ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Rikke Hagmann Schmidt. The company is owned by Rikke Hagmann Schmidt. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -165,416 the year before. Equity in the 2025 report amounted to DKK -138,404.